RMD – ResMed Inc.
Float Short %
5.85
Margin Of Safety %
4
Put/Call OI Ratio
3.07
EPS Next Q Diff
0.14
EPS Last/This Y
1.32
EPS This/Next Y
1.07
Price
270.29
Target Price
301.88
Analyst Recom
1.9
Performance Q
7.11
Relative Volume
1.3
Beta
0.84
Ticker: RMD
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | RMD | 285.09 | 3.17 | 0.59 | 28167 |
| 2025-08-18 | RMD | 286.09 | 3.34 | 1.13 | 18424 |
| 2025-08-19 | RMD | 286.08 | 3.29 | 1.00 | 18598 |
| 2025-08-20 | RMD | 289.09 | 3.31 | 4.75 | 18683 |
| 2025-08-21 | RMD | 288.4 | 3.43 | 1.31 | 19618 |
| 2025-08-22 | RMD | 293.61 | 3.41 | 0.98 | 19744 |
| 2025-08-25 | RMD | 285.63 | 3.43 | 9.97 | 19786 |
| 2025-08-26 | RMD | 285.12 | 3.43 | 8.11 | 19836 |
| 2025-08-27 | RMD | 281.98 | 3.43 | 0.18 | 19856 |
| 2025-08-28 | RMD | 275.3 | 3.43 | 16.02 | 19848 |
| 2025-08-29 | RMD | 274.25 | 3.54 | 0.68 | 20381 |
| 2025-09-02 | RMD | 270.92 | 3.51 | 4.27 | 20427 |
| 2025-09-03 | RMD | 269.19 | 3.54 | 0.09 | 20689 |
| 2025-09-04 | RMD | 273.84 | 3.40 | 7.86 | 20894 |
| 2025-09-05 | RMD | 277.18 | 3.45 | 0.92 | 21129 |
| 2025-09-08 | RMD | 279.47 | 3.45 | 1.13 | 21137 |
| 2025-09-09 | RMD | 279.23 | 3.42 | 1.32 | 21132 |
| 2025-09-10 | RMD | 270.34 | 3.42 | 1.44 | 21156 |
| 2025-09-11 | RMD | 274.75 | 3.38 | 0.13 | 21050 |
| 2025-09-12 | RMD | 270.3 | 3.07 | 1.97 | 21615 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | RMD | 285.08 | 13.7 | 233.1 | 10.90 |
| 2025-08-18 | RMD | 286.20 | 13.7 | 239.5 | 10.90 |
| 2025-08-19 | RMD | 286.04 | 13.7 | 230.1 | 10.87 |
| 2025-08-20 | RMD | 289.05 | 13.7 | 251.0 | 10.87 |
| 2025-08-21 | RMD | 288.37 | 13.7 | 226.0 | 10.87 |
| 2025-08-22 | RMD | 293.77 | 13.7 | 267.1 | 10.87 |
| 2025-08-25 | RMD | 285.70 | 13.7 | 177.7 | 10.87 |
| 2025-08-26 | RMD | 285.17 | 13.7 | 226.4 | 10.87 |
| 2025-08-27 | RMD | 281.98 | 13.7 | 209.0 | 10.87 |
| 2025-08-28 | RMD | 275.32 | 13.7 | 185.1 | 10.87 |
| 2025-08-29 | RMD | 274.73 | 13.7 | 226.1 | 10.87 |
| 2025-09-02 | RMD | 271.01 | 13.7 | 205.9 | 10.87 |
| 2025-09-03 | RMD | 269.20 | 13.7 | 217.8 | 10.87 |
| 2025-09-04 | RMD | 273.78 | 13.7 | 263.4 | 10.87 |
| 2025-09-05 | RMD | 277.05 | 13.7 | 253.5 | 10.87 |
| 2025-09-08 | RMD | 279.46 | 13.7 | 247.5 | 10.87 |
| 2025-09-09 | RMD | 279.19 | 13.7 | 228.8 | 10.87 |
| 2025-09-10 | RMD | 270.31 | 13.7 | 169.1 | 10.87 |
| 2025-09-11 | RMD | 274.61 | 13.7 | 260.2 | 10.87 |
| 2025-09-12 | RMD | 270.29 | 13.7 | 200.2 | 10.87 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | RMD | -10.75 | 1.37 | 6.19 |
| 2025-08-18 | RMD | -9.31 | 0.83 | 6.20 |
| 2025-08-19 | RMD | -9.54 | 0.83 | 6.20 |
| 2025-08-20 | RMD | -9.54 | 0.83 | 6.20 |
| 2025-08-21 | RMD | -9.54 | 0.83 | 6.20 |
| 2025-08-22 | RMD | -9.54 | 0.83 | 6.20 |
| 2025-08-25 | RMD | -9.55 | -1.56 | 6.20 |
| 2025-08-26 | RMD | -9.27 | -1.56 | 6.20 |
| 2025-08-27 | RMD | -9.27 | -1.56 | 6.14 |
| 2025-08-28 | RMD | -9.27 | -1.56 | 6.14 |
| 2025-08-29 | RMD | -9.27 | -1.56 | 6.14 |
| 2025-09-02 | RMD | -9.27 | -1.52 | 6.14 |
| 2025-09-03 | RMD | -9.27 | -1.52 | 6.14 |
| 2025-09-04 | RMD | -9.54 | -1.52 | 6.14 |
| 2025-09-05 | RMD | -8.72 | -1.52 | 6.14 |
| 2025-09-08 | RMD | -8.53 | -1.53 | 6.14 |
| 2025-09-09 | RMD | -9.25 | -1.53 | 6.14 |
| 2025-09-10 | RMD | -9.25 | -1.53 | 6.14 |
| 2025-09-11 | RMD | -9.25 | -1.53 | 5.85 |
| 2025-09-12 | RMD | -7.55 | -1.53 | 5.85 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.55
Avg. EPS Est. Current Quarter
2.5
Avg. EPS Est. Next Quarter
2.69
Insider Transactions
-7.55
Institutional Transactions
-1.53
Beta
0.84
Average Sales Estimate Current Quarter
1331
Average Sales Estimate Next Quarter
1398
Fair Value
281.47
Quality Score
85
Growth Score
96
Sentiment Score
65
Actual DrawDown %
10.3
Max Drawdown 5-Year %
-54
Target Price
301.88
P/E
28.41
Forward P/E
22.39
PEG
2.54
P/S
7.69
P/B
6.63
P/Free Cash Flow
23.8
EPS
9.51
Average EPS Est. Cur. Y
10.87
EPS Next Y. (Est.)
11.94
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
27.22
Relative Volume
1.3
Return on Equity vs Sector %
-1.4
Return on Equity vs Industry %
14.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.34
EBIT Estimation
200.2
ResMed Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 10600
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
stock quote shares RMD – ResMed Inc. Stock Price stock today
news today RMD – ResMed Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RMD – ResMed Inc. yahoo finance google finance
stock history RMD – ResMed Inc. invest stock market
stock prices RMD premarket after hours
ticker RMD fair value insiders trading